Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop- 2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex

作者: Luciana B. P. Sâmia , Gabrieli L. Parrilha , Jeferson G. Da Silva , Jonas P. Ramos , Elaine M. Souza-Fagundes

DOI: 10.1007/S10534-016-9933-5

关键词: TopoisomeraseThioredoxin reductaseCytotoxic T cellActive siteStereochemistryChalconeChemistryMonocytic leukemiaStructure–activity relationshipSemicarbazone

摘要: Complexes [Au(PyCT4BrPh)Cl]Cl (1), [Pt(PyCT4BrPh)Cl]0.5KCl (2), and [Pd(PyCT4BrPh)Cl]KCl (3) were obtained with 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone (HPyCT4BrPh). Although complexes (2) did not exhibit potent cytotoxic activity, HPyCT4BrPh its gold(III) complex (1) proved to be highly against HL-60 (human promyelocytic leukemia) THP-1 monocytic cells, MDA-MB 231 MCF-7 breast adenocarcinoma) solid tumor cells. Except for upon coordination a 2- 3-fold increase in the effect was observed. An investigation on possible biological targets of carried out. Complex but free inhibits enzymatic activity thioredoxin reductase (TrxR). The affinity 1 TrxR suggests metal binding selenol residue active site enzyme. While inactive, able inhibit topoisomerase IB (Topo IB) activity. Hence, inhibition Topo could contribute mechanism action (1).

参考文章(46)
Pritam Thapa, Kyu-Yeon Jun, Tara Man Kadayat, Chanmi Park, Zhi Zheng, Til Bahadur Thapa Magar, Ganesh Bist, Aarajana Shrestha, Younghwa Na, Youngjoo Kwon, Eung-Seok Lee, Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents. Bioorganic & Medicinal Chemistry. ,vol. 23, pp. 6454- 6466 ,(2015) , 10.1016/J.BMC.2015.08.018
Heloisa Beraldo, Dinorah Gambino, The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. Mini-reviews in Medicinal Chemistry. ,vol. 4, pp. 31- 39 ,(2003) , 10.2174/1389557043487484
Martina Cappelletti, Alessandro Presentato, Giorgio Milazzo, Raymond J. Turner, Stefano Fedi, Dario Frascari, Davide Zannoni, Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genes. Frontiers in Microbiology. ,vol. 6, pp. 1- 15 ,(2015) , 10.3389/FMICB.2015.00393
Sara Vieira, Silvia Castelli, Alessandro Desideri, Importance of a stable topoisomerase IB clamping for an efficient DNA processing: Effect of the Lys(369)Glu mutation. International Journal of Biological Macromolecules. ,vol. 81, pp. 76- 82 ,(2015) , 10.1016/J.IJBIOMAC.2015.07.044
Karina SO Ferraz, Nayane F Silva, Jeferson G Da Silva, Nivaldo L Speziali, Isolda C Mendes, Heloisa Beraldo, None, Structural studies on acetophenone- and benzophenone-derived thiosemicarbazones and their zinc(II) complexes Journal of Molecular Structure. ,vol. 1008, pp. 102- 107 ,(2012) , 10.1016/J.MOLSTRUC.2011.11.035
Karina OS Ferraz, Gabriele MM Cardoso, Caryne Margotto Bertollo, Elaine M Souza-Fagundes, Nivaldo Speziali, Carlos L Zani, Isolda C Mendes, Maria A Gomes, Heloisa Beraldo, None, N(4)-tolyl-2-benzoylpyridine-derived thiosemicarbazones and their palladium(II) and platinum(II) complexes: Cytotoxicity against human solid tumor cells Polyhedron. ,vol. 30, pp. 315- 321 ,(2011) , 10.1016/J.POLY.2010.10.014
Josane A Lessa, Isolda C Mendes, Paulo RO da Silva, Marcella A Soares, Raquel G dos Santos, Nivaldo L Speziali, Nelilma C Romeiro, Eliezer J Barreiro, Heloisa Beraldo, None, 2-Acetylpyridine thiosemicarbazones: Cytotoxic activity in nanomolar doses against malignant gliomas European Journal of Medicinal Chemistry. ,vol. 45, pp. 5671- 5677 ,(2010) , 10.1016/J.EJMECH.2010.09.021
Josane A. Lessa, Karina S. O. Ferraz, Juliana C. Guerra, Luana F. de Miranda, Carla F. D. Romeiro, Elaine M. Souza-Fagundes, Paulo Jorge S. Barbeira, Heloisa Beraldo, Spectroscopic and electrochemical characterization of gold(I) and gold(III) complexes with glyoxaldehyde bis(thiosemicarbazones): cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity Biometals. ,vol. 25, pp. 587- 598 ,(2012) , 10.1007/S10534-012-9547-5
Edward R.T. Tiekink, Antimony and bismuth compounds in oncology. Critical Reviews in Oncology Hematology. ,vol. 42, pp. 217- 224 ,(2002) , 10.1016/S1040-8428(01)00217-7